This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of active pharmaceutical ingredients (APIs). Its structure, featuring a fluorine atom and a methoxy group, makes it valuable in the development of drugs targeting the central nervous system (CNS). It is often employed in the creation of compounds with potential antidepressant, antipsychotic, or anxiolytic properties. Additionally, its chiral nature allows for the production of enantiomerically pure drugs, which can enhance efficacy and reduce side effects. Researchers also explore its use in the design of radiopharmaceuticals for diagnostic imaging due to the presence of the fluorine atom, which can be replaced with fluorine-18 for positron emission tomography (PET) applications.